Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.82M Sell
5,200
-1,700
-25% -$874K ﹤0.01% 3533
2026
Q1
$3M Buy
6,900
+1,400
+25% +$617K ﹤0.01% 3465
2025
Q4
$1.81M Buy
5,500
+2,700
+96% +$868K ﹤0.01% 4032
2025
Q3
$895K Buy
2,800
+1,200
+75% +$331K ﹤0.01% 4702
2025
Q2
$440K Sell
1,600
-1,200
-43% -$244K ﹤0.01% 4981
2025
Q1
$516K Sell
2,800
-14,800
-84% -$3.42M ﹤0.01% 4792
2024
Q4
$3.47M Buy
17,600
+16,300
+1,254% +$3.13M ﹤0.01% 3165
2024
Q3
$271K Buy
+1,300
New +$277K ﹤0.01% 5266

Other funds holding NVMI

Israel Englander's NVMI Position: Q2 2026 in Review

Israel Englander increased its Nova (NVMI) stake by 2.2% in Q2 2026, buying an estimated $38.5K and bringing the position to 3,414 shares worth $1.85M. The position accounts for ﹤0.01% of the portfolio, ranked #3881.

Israel Englander first reported a position in NVMI in Q4 2013 and has held it in 34 quarters since. The position peaked at $92.7M in Q3 2024. 342 funds tracked by Wall St. Rank hold NVMI as of Q2 2026.

  • Israel Englander held 3,414 shares of Nova worth $1.85M as of Q2 2026.
  • Israel Englander bought 75 Nova shares in Q2 2026, an estimated $38.5K.
  • Nova made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #3881 holding.
  • Israel Englander first reported a position in Nova in Q4 2013 and has held it in 34 quarters since.
  • Israel Englander's Nova position peaked at $92.7M in Q3 2024.
  • 342 funds tracked by Wall St. Rank held Nova as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.